Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 158, Issue 5 III, 1998, Pages

  Postma, D S ^a   Kerstjens, H A M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0031761533     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.158.supplement_2.13tac170     Document Type: Conference Paper

References (20)

1. Xu, X., B. Rijcken, J. P. Scheuten, and S. T. Weiss. 1997. Airways responsiveness and development and remission of chronic respiratory symptoms in adults. Lancet 350:1431-1434.
2. Peat, J. K., A. J. Woolcock, and K. Cullen. 1987. Rate of decline of lung function in subjects with asthma. Eur. J. Respir. Dis. 70:171-179.
3. Kerstjens, H. A. M., S. E. Overbeek, J. P. Scheuten, P. L. P. Brand, D. S. Postma, and the Dutch CNSLD Study Group. 1993. Airways hyperresponsiveness, bronchodilator response, allergy and smoking predict improvement in FEV1 during long-term inhaled corticosteroid treatment. Eur. Respir. J. 6:868-876.
4. Tashkin, D. P., M. D. Altose, E. R. Bleecker, J. E. Connett, R. E. Kanner, W. W. Lee, and R. A. Wise for the Lung Health Study Research Group. 1992. The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. Am. Rev. Respir. Dis. 145:301-310.
5. Tashkin, D. P., M. D. Altose, J. E. Connett, R. E. Kanner, W. W. Lee, and R. A. Wise, for the Lung Health Study Research Group. 1996. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. Am. J. Respir. Cm. Care Med. 153:1802-1811.
6. Brand, P. L. P., D. S. Postma, H. A. M. Kerstjens, G. H. Koëter, and the Dutch CNSLD Study Group. 1991. Relationship of airway hyperresponsiveness to respiratory symptoms and diurnal peak flow variation in patients with obstructive lung disease. Am. Rev. Respir. Dis. 143: 916-921.
7. Jeffery, P. K. 1997. Pathology of asthma and COPD: a synopsis. Eur. Respir. Rev. 7:43, 111-118.
8. Saetta, M. 1997. Central airways inflammation in the development of COPD. Eur. Respir. Rev. 7:43, 109-110.
9. 1. Am. J. Respir. Crit. Care Med. 155:852-857.
10. Sont, J. K., H. J. M. Van Krieken, C. E. Evertse, R. Hooijer, L. N. A. Willems, and P. J. Sterk. 1996. Relationship between the inflammatory infiltrate in bronchial biopsies and clinical severity of asthma in patients treated with inhaled steroids. Thorax 51:496-502.
11. Mullen, J. B. M., B. R. Wiggs, J. L. Wright, J. C. Hogg, and P. D. Pare. 1986. Nonspecific airway reactivity in cigarette smokers: relationship to airway pathology and baseline lung function. Am. Rev. Respir. Dis. 1:120-125.
12. Hogg, J. C., P. T. Macklem, and W. M. Thurlbeck. 1968. Site and nature of airway obstruction in chronic obstructive lung disease. N. Engl. J. Med. 278:1355-1360.
13. Hamid, Q., Y. Song, T. C. Kotsimbos, E. Minshall, T. R. Bai, R. G. Hegele, and J. C. Hogg. 1997. Inflammation of small airways in asthma. J. Allergy Clin. Immunol. 100:44-51.
14. Kuwano, K., C. Bosken, P. D. Pare, T. Bai, B. Wiggs, and J. C. Hogg. 1993. Small airway dimensions in asthma and chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 148:1220-1225.
15. Pare, P. D., and T. R. Bai. 1996. Airway wall remodelling in chronic obstructive pulmonary diseases. Eur. Respir. Rev. 6:39, 259-263.
16. Postma, D. S., G. H. Koëter, and K. De Vries. 1989. Clinical expression of airway hyperreactivity in adults, Clin. Rev. Allergy 7:321-343.
17. Oosterhoff, Y., M. A. M. Jansen, D. S. Postma, and G. H. Koëter. 1993. Airway responsiveness to adenosine-5′ monophosphate in smokers and nonsmokers with atopic asthma. J. Allergy Clin. Immunol. 92:773-776.
18. Oosterhoff, Y., J. W. De Jong, M. A. M. Jansen, G. H. Koëter, and D. S. Postma. 1993. Airway responsiveness to adenosine-5′ monophosphate in chronic obstructive pulmonary disease is determined by smoking. Am. Rev. Respir. Dis. 147:553-558.
19. Weersink, E. J. M., W. R. Douma, D. S. Postma, and G. H. Koëter. 1997. Fluticasone propionate, salmeterol xinafoate, and their combination in the treatment of nocturnal asthma. Am. J. Respir. Crit. Care Med. 155:1241-1246.
20. Rutgers, S. R., G. H. Koëter, Th. W. Van der Mark, and D. S. Postma. 1998. Short term treatment with budesonide does not improve hyperresponsiveness to adenosine-5′-monophosphate in COPD. Am. J. Respir. Crit. Care Med. 157:880-886.